Primary Site >> Pancreatic Cancer

Gene >> CFH

  • 1999
  • 2000
  • 2012
  • 2018
Ref: Locoregional/systemic chemotherapy of locally advanced/metastasized pancreatic cancer with a combination of mitomycin-C and gemcitabine and simultaneous follow-up by imaging methods and tumor markers.
PMID: 10470175
Ref: Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
PMID: 11072167
Ref: Identification of potential prognostic biomarkers in patients with untreated, advanced pancreatic cancer from a phase 3 trial (Cancer and Leukemia Group B 80303).
PMID: 21713765
Ref: Towards abdominal MRI-based treatment planning using population-based Hounsfield units for bulk density assignment.
PMID: 29952320